HNSCC Cell Research Roadmap

The HNSCC (Head and Neck Squamous Cell Carcinoma) cell research roadmap is a systematic experimental planning framework for elucidating the mechanisms of tumorigenesis, metastasis pathways, and treatment resistance. It aims to reveal the disease progression and screen intervention targets from multiple dimensions, including molecular, cellular, and microenvironmental perspectives. This section details the typical research stages of this roadmap, including five core components: clinical sample collection and primary cell culture, multi-omics characterization, in vitro functional validation, in vivo animal model establishment, and translational validation. In the initial stage, pathologically confirmed HNSCC tissue and paired adjacent normal tissue samples are obtained. Primary cell lines are established using tissue digestion and selective culture methods, and STR identification is performed to ensure lineage traceability. At the multi-omics level, whole-exome sequencing (WES) is used to screen for mutation characteristics (such as TP53, NOTCH1, and PIK3CA), transcriptome sequencing is used to analyze differentially expressed genes and fusion genes, and single-cell RNA sequencing (scRNA-seq) is used to reveal intratumoral heterogeneity and tumor stem cell subsets. In vitro functional experiments include CCK-8 proliferation curves, Transwell migration/invasion, cell scratch healing, and suspension spheroidization assays. Simultaneously, CRISPR-Cas9 or lentiviral overexpression systems are used to validate the functional gain/loss of candidate genes. In vivo models are constructed using subcutaneous xenograft (CDX) or patient-derived xenograft (PDX) models, and tumor growth and lymph node metastasis tendencies are assessed through in vivo imaging and immunohistochemistry. At the translational level, drug sensitivity screening (e.g., cisplatin, 5-FU, cetuximab) combined with organoid drug sensitivity testing can be conducted, and efficacy prediction models can be established based on biomarkers (PD-L1 expression, tumor mutational burden (TMB)). By integrating a temporal sample library and multidimensional validation logic, this roadmap provides a systematic technical roadmap for elucidating the invasion and metastasis mechanisms of HNSCC and developing synergistic targeted therapies.